Suppr超能文献

血管危险因素和血管功能障碍在阿尔茨海默病中的作用。

Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.

作者信息

Dickstein Dara L, Walsh Jessica, Brautigam Hannah, Stockton Steven D, Gandy Samuel, Hof Patrick R

机构信息

Department of Neuroscience and Kastor Neurobiology of Aging Laboratories, Mount Sinai School of Medicine, New York, NY, USA.

出版信息

Mt Sinai J Med. 2010 Jan-Feb;77(1):82-102. doi: 10.1002/msj.20155.

Abstract

Recent findings indicate that vascular risk factors and neurovascular dysfunction play integral roles in the pathogenesis of Alzheimer's disease. In addition to aging, the most common risk factors for Alzheimer's disease are apolipoprotein e4 allele, hypertension, hypotension, diabetes, and hypercholesterolemia. All of these can be characterized by vascular pathology attributed to conditions such as cerebral amyloid angiopathy and subsequent blood-brain barrier dysfunction. Many epidemiological, clinical, and pharmacotherapeutic studies have assessed the associations between such risk factors and Alzheimer's disease and have found positive associations between hypertension, hypotension, and diabetes mellitus. However, there are still many conflicting results from these population-based studies, and they should be interpreted carefully. Recognition of these factors and the mechanisms by which they contribute to Alzheimer's disease will be beneficial in the current treatment regimens for Alzheimer's disease and in the development of future therapies. Here we discuss vascular factors with respect to Alzheimer's disease and dementia and review the factors that give rise to vascular dysfunction and contribute to Alzheimer's disease.

摘要

最近的研究结果表明,血管危险因素和神经血管功能障碍在阿尔茨海默病的发病机制中起着不可或缺的作用。除衰老外,阿尔茨海默病最常见的危险因素是载脂蛋白E4等位基因、高血压、低血压、糖尿病和高胆固醇血症。所有这些都可表现为血管病变,如脑淀粉样血管病及随后的血脑屏障功能障碍。许多流行病学、临床和药物治疗研究评估了这些危险因素与阿尔茨海默病之间的关联,发现高血压、低血压和糖尿病之间存在正相关。然而,这些基于人群的研究仍有许多相互矛盾的结果,应谨慎解读。认识这些因素及其导致阿尔茨海默病的机制,将有助于当前阿尔茨海默病的治疗方案及未来疗法的开发。在此,我们讨论与阿尔茨海默病和痴呆相关的血管因素,并综述导致血管功能障碍及促成阿尔茨海默病的因素。

相似文献

1
Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.
Mt Sinai J Med. 2010 Jan-Feb;77(1):82-102. doi: 10.1002/msj.20155.
3
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25.
4
Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease.
J Neurol Sci. 2007 Jun 15;257(1-2):194-201. doi: 10.1016/j.jns.2007.01.030. Epub 2007 Feb 27.
5
Analysis of genetics and risk factors of Alzheimer's Disease.
Neuroscience. 2016 Jun 14;325:124-31. doi: 10.1016/j.neuroscience.2016.03.051. Epub 2016 Mar 26.
6
Vascular and metabolic dysfunction in Alzheimer's disease: a review.
Exp Biol Med (Maywood). 2011 Jul;236(7):772-82. doi: 10.1258/ebm.2011.010355. Epub 2011 Jun 16.
8
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Biochim Biophys Acta. 2016 May;1862(5):887-900. doi: 10.1016/j.bbadis.2015.12.016. Epub 2015 Dec 17.
9
Vascular risk factors and progression in Alzheimer's disease.
Geriatr Gerontol Int. 2011 Apr;11(2):211-4. doi: 10.1111/j.1447-0594.2010.00669.x. Epub 2010 Dec 10.
10
Interventions for heart disease and their effects on Alzheimer's disease.
Neurol Res. 2006 Sep;28(6):630-6. doi: 10.1179/016164106X130515.

引用本文的文献

1
: detecting early signs of neurodegenerative diseases through activity and sleep analysis.
Front Neurosci. 2025 Aug 19;19:1617758. doi: 10.3389/fnins.2025.1617758. eCollection 2025.
2
The influence of cardiovascular fitness and ventilatory efficiency on fMRI assessed cerebrovascular reactivity in older adults.
Front Physiol. 2025 May 8;16:1581187. doi: 10.3389/fphys.2025.1581187. eCollection 2025.
3
Evidence of cortical vascular impairments in early stage of Alzheimer's transgenic mice: Optical imaging.
J Cereb Blood Flow Metab. 2025 May;45(5):960-976. doi: 10.1177/0271678X241304893. Epub 2024 Dec 18.
4
The duality of amyloid-β: its role in normal and Alzheimer's disease states.
Mol Brain. 2024 Jul 17;17(1):44. doi: 10.1186/s13041-024-01118-1.
6
Comorbid Conditions Are Associated With Cognitive Impairment in Native Hawaiians and Pacific Islanders.
Int J Aging Hum Dev. 2024 Dec;99(4):420-433. doi: 10.1177/00914150241231186. Epub 2024 Feb 7.
9
The Late Stage of Abnormal Aging: Dementia.
Adv Exp Med Biol. 2023;1419:157-167. doi: 10.1007/978-981-99-1627-6_12.

本文引用的文献

1
Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surface.
J Neurochem. 2009 Jul;110(1):220-30. doi: 10.1111/j.1471-4159.2009.06126.x. Epub 2009 Apr 27.
2
Blood pressure and the risk for dementia: a double edged sword.
Ageing Res Rev. 2009 Apr;8(2):61-70. doi: 10.1016/j.arr.2008.11.001. Epub 2008 Nov 21.
3
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
J Clin Invest. 2008 Dec;118(12):4002-13. doi: 10.1172/JCI36663. Epub 2008 Nov 13.
4
Cognitive decline and low blood pressure: the other side of the coin.
Clin Exp Hypertens. 2008 Nov;30(8):711-9. doi: 10.1080/10641960802573344.
5
Hypertension and cognitive function.
Clin Exp Hypertens. 2008 Nov;30(8):701-10. doi: 10.1080/10641960802563584.
6
Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis.
J Neurosci. 2008 Nov 12;28(46):12097-106. doi: 10.1523/JNEUROSCI.2635-08.2008.
9
Risk factors for vascular dementia: hypotension as a key point.
Vasc Health Risk Manag. 2008;4(2):395-402. doi: 10.2147/vhrm.s2434.
10
Vascular risk factors, cognitive decline, and dementia.
Vasc Health Risk Manag. 2008;4(2):363-81. doi: 10.2147/vhrm.s1839.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验